Cyabra Completes SPAC Merger, Lists on Nasdaq Amid Going Concern Warning and Significant Dilution
CYAB is trading near its 52-week low of $2.26 (4.4% below the low) on elevated volume (15× avg).
Summary
Cyabra, Inc. completed its SPAC merger and began trading on Nasdaq, but disclosed a 'going concern' warning in its financials, despite a critical $8.0 million capital infusion and significant dilution from various equity issuances.
Key Events · Financing and Capital Events · CYAB
-
SPAC Merger Completed & Nasdaq Listing
Cyabra, Inc. (formerly Trailblazer Holdings, Inc.) completed its business combination with Cyabra Strategy Ltd. and began trading on Nasdaq under the ticker 'CYAB' on March 27, 2026.
-
Going Concern Warning Issued
The company's 2025 audited financial statements include a 'substantial doubt about its ability to continue as a going concern' due to significant accumulated losses ($47.37 million) and negative operating cash flow ($8.14 million).
-
Critical Capital Infusion & Debt Conversion
The merger included an $8.0 million PIPE investment ($5.5 million cash, $2.5 million debt extinguishment) and the conversion of $7.0 million in convertible notes (fair value $12.9 million) into common and preferred stock.
-
Significant Dilution from Equity Issuances
Post-merger, 13.81 million common shares are outstanding, with a fully diluted count of 22.35 million shares. This includes 400,000 RSUs for key employees, 400,000 PIPE Warrants (exercise price $11.50), 207,000 shares for deferred underwriting fees, and 2 million shares for legal fees.
Analysis · CYAB · Technology
Cyabra, Inc. has completed its business combination, transitioning from a SPAC to a publicly traded operating company on Nasdaq under the ticker 'CYAB'. This is a significant corporate milestone, but the accompanying financial disclosures reveal substantial challenges. The company's 2025 audited financials include an explicit 'going concern' warning, citing significant accumulated losses and negative operating cash flow. While a $8.0 million PIPE investment (including $5.5 million in cash) provides a critical capital infusion, it comes with substantial dilution. The fully diluted share count post-merger is 22.35 million, compared to 13.81 million common shares outstanding. A complex new capital structure includes three series of preferred stock with varying conversion prices, some significantly above the current stock price. Notably, the Sponsor's $5.33 million promissory note converted into $15.99 million stated value of preferred stock, representing a 300% premium on the principal. The issuance of 2 million shares for legal fees and 207,000 shares for deferred underwriting commissions further contributes to dilution. The new executive team and board are now tasked with navigating these financial headwinds and executing the company's strategy to address the going concern.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 41.8% of the 507 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.39%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CYAB was trading at $2.16 on NASDAQ in the Technology sector, with a market capitalization of approximately $5.9M. The 52-week trading range was $2.26 to $14.91. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.